
Theodore Darkow, PharmD
Advertisement
Articles by Theodore Darkow, PharmD
Advertisement
Latest Updated Articles
Medical Costs After Initiation of Drug Treatment for Overactive Bladder: Effects of Selection Bias on Cost EstimatesPublished: July 15th 2005 | Updated:
Coverage and Use of Cancer Therapies in the Treatment of Chronic Myeloid LeukemiaPublished: November 30th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
2
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
3
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
4
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
5



